Correlation Between Adamis Pharma and Lifecore Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adamis Pharma and Lifecore Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adamis Pharma and Lifecore Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adamis Pharma and Lifecore Biomedical, you can compare the effects of market volatilities on Adamis Pharma and Lifecore Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adamis Pharma with a short position of Lifecore Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adamis Pharma and Lifecore Biomedical.

Diversification Opportunities for Adamis Pharma and Lifecore Biomedical

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Adamis and Lifecore is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Adamis Pharma and Lifecore Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifecore Biomedical and Adamis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adamis Pharma are associated (or correlated) with Lifecore Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifecore Biomedical has no effect on the direction of Adamis Pharma i.e., Adamis Pharma and Lifecore Biomedical go up and down completely randomly.

Pair Corralation between Adamis Pharma and Lifecore Biomedical

Given the investment horizon of 90 days Adamis Pharma is expected to under-perform the Lifecore Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Adamis Pharma is 1.03 times less risky than Lifecore Biomedical. The stock trades about -0.22 of its potential returns per unit of risk. The Lifecore Biomedical is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  628.00  in Lifecore Biomedical on October 23, 2024 and sell it today you would earn a total of  20.00  from holding Lifecore Biomedical or generate 3.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy24.29%
ValuesDaily Returns

Adamis Pharma  vs.  Lifecore Biomedical

 Performance 
       Timeline  
Adamis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Lifecore Biomedical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Adamis Pharma and Lifecore Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adamis Pharma and Lifecore Biomedical

The main advantage of trading using opposite Adamis Pharma and Lifecore Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adamis Pharma position performs unexpectedly, Lifecore Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will offset losses from the drop in Lifecore Biomedical's long position.
The idea behind Adamis Pharma and Lifecore Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk